Latest in Viking Therapeutics’ stock soars 18% as data on oral weight loss drug looms
Sort by
756 items
-
Business - MarketWatch
Viking Therapeutics’ stock soars 18% as data on oral weight-loss drug looms
Viking Therapeutics Inc.’s stock soared 18% Thursday, after the biotech, which is developing a weight-loss drug in pill form that has raised high hopes among analysts and investors, posted earnings ...8 hours ago -
Top stories - CBS News
Lilly's weight loss drug shortage deemed over, but hurdles remain
Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.Yesterday -
Tech - VentureBeat
Dotmatics aims to speed drug development, break data silos with Geneious Luma
It leverages AI and machine learning to automate workflows, enabling scientists to manage complex biological data with greater accuracy.2 days ago -
Business - Financial Times
Rachel Reeves’s Budget balancing act
The chancellor’s tax plans must avoid overburdening business and investors3 days ago -
Top stories - BBC News
Weight loss jabs for jobless not dystopian, says Wes Streeting
The government is looking into whether weight-loss drugs can help get more people back to work.4 days ago -
World - The Guardian
From fashion to the food industry: 11 ways that weight-loss drugs have changed the world
The growing – and sometimes secret – use of drugs containing semaglutide has had a huge impact on how we live … but where will it end?. For a phenomenon that has such visible results, there is huge ...4 days ago -
Business - MarketWatch
Weight-loss drugs may reduce opioid and alcohol abuse by up to 50%, study finds
Weight-loss drugs such as Ozempic, made by Denmark’s Novo Nordisk, can reduce rates of opioid and alcohol abuse by up to 50%, according to a new study that supports expectations the drugs can offer ...5 days ago -
Top stories - BBC News
How will weight-loss drugs change our relationship with food?
The rise of these treatments has major implications for how we think about obesity, says James Gallagher.5 days ago -
Sports - CBS Sports
LOOK: Former NFL OT Jake Long shows off dramatic weight loss at Michigan Sports Hall of Fame induction
Long has become another in a growing list of offensive linemen to shed weight in retirement6 days ago - NFL -
World - The Guardian
Weight loss jabs not ‘quick fix’ for UK worklessness, health experts warn
Scientists say using the drugs to get people back into work could carry logistical and ethical problems. Weight loss jabs are not a “quick fix” and the health secretary’s plan to use them to help ...6 days ago - United Kingdom -
World - The Guardian
Weight-loss drugs could be key in lowering US obesity rates – experts
Medications like Ozempic ‘transformed’ diabetes care because they improved health outcomes, say experts. Obesity rates have decreased slightly in the US and while it’s too early to say whether the ...6 days ago -
Top stories - BBC News
Weight loss injections: How do drugs like Wegovy and Mounjaro work?
NHS experts report unprecedented demand for the new generation of obesity treatments.October 18 -
Politics - The Hill
Weight loss drugs may help reduce drug and alcohol misuse: Research
Weight loss medications such as Ozempic may be able to cut drug and alcohol misuse in half, according to a new study from the scientific journal Addiction. The research, published Thursday, found ...October 17 -
Business - MarketWatch
Travelers’ stock soars as earnings triple despite record catastrophe losses
ravelers’ stock surges toward another record after earnings beat expectations by a wide margin, amid a sharp improvement in underlying profitability.October 17 -
Business - MarketWatch
Sage Therapeutics’ stock falls 4.7% as biotech unveils plan to cut 33% of workforce
More than 165 jobs to go as company seeks to extend cash runway and focus on postpartum drug launch.October 17 -
Top stories - CBS News
Weight loss drugs could help with alcohol, opioid addiction, study says
Drugs like Mounjaro and Ozempic, which many use for weight loss, may also help patients suffering from addiction, according to a new study.October 17 -
Top stories - CBS News
Weight loss drugs could help patients struggling with addiction, study says
A new study shows diabetes drugs like Mounjaro and Ozempic, which people also take to lose weight, may help patients suffering from addiction. CBS News contributor Dr. Celine Gounder explains.October 17 -
World - Financial Times
Weight-loss drugs show promise in tackling opioid and alcohol abuse
Analysis points to potential of drugs such as Ozempic beyond tackling obesity and diabetesOctober 17 -
Business - MarketWatch
Small-cap biotech Jaguar Health’s stock jumps as it launches treatment for a painful side effect of cancer treatment
The stock of small-cap biotech Jaguar Health Inc. rose 7% on Wednesday, after the company launched its gelclair treatment for oral mucositis, a common side effect suffered by head and neck cancer ...October 16 -
Top stories - NBC News
Eli Lilly to trial use of weight loss drugs to combat unemployment in U.K.
U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with the U.K.October 16 -
Top stories - BBC News
NHS needs better plan around weight loss jabs, warn experts
Experts call for an urgent review of obesity treatment services amid booming demand for weight loss jabs.October 16 -
World - The Guardian
Weight-loss drug firm accused of prioritising profits after halting insulin pen production
Novo Nordisk’s decision will force people in developing countries to use outdated glass vials and syringes, warn campaigners. The pharmaceutical company behind injectable weight-loss drugs has been ...October 16 -
Business - CNBC
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
Medicare coverage of the drugs would up federal spending by $35 billion from 2026 to 2034. Meanwhile, CNBC tests Abbott's continuous glucose monitor Lingo.October 15 -
Business - The New York Times
Trump Media’s Stock Price Soars, Adding $2 Billion to Trump’s Stake
The sharp rise in the share price of the parent of Truth Social has added about $2 billion to the net worth of former President Donald J. Trump.October 15 - Donald Trump -
Top stories - BBC News
Weight Loss Jabs for Jobs?
Health Secretary says jabs could be given to help people get back into work.October 15 -
World - The New York Times
Could Weight-Loss Drugs Help Get People Back to Work? The U.K. Wants to Find Out.
The British government announced a multimillion dollar pharmaceutical partnership with Eli Lilly, including a trial that will study the impact of a weight-loss drug on work and productivity.October 15 -
Top stories - BBC News
Unemployed could get weight loss jabs to return to work
The health secretary announces trials to explore the effect of weight loss drugs on worklessness.October 15 -
Business - CNBC
Eli Lilly to trial use of weight loss drugs to combat unemployment in UK
U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with the U.K.October 15 -
Top stories - BBC News
Will weight-loss drugs help jobless get back into work?
Ministers are lauding the new generation of weight-loss drugs - but are they really the solution?October 15 -
Sports - CBS Sports
NFL 2024 playoff picture, standings for Week 7: Chiefs, Vikings lone unbeaten teams; Falcons soaring in NFC
An early look at the playoff standings with one third of the season completedOctober 15 - NFL -
Top stories - NBC News
Maine shooting survivors claim Army negligence and FDA's weight-loss drug decision: Morning Rundown
Detroit, TCF Center, 2024 election, Harris in Pennsylvania, Lewiston Maine shooting, Trump rally shooting survivors, giant pandas at National Zoo, Mount EverestOctober 15 -
Politics - The Hill
FDA will reconsider decision barring copycat versions of Lilly weight loss drug
The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and diabetes drug from its official shortage list and allow compounding ...October 14 -
Business - MarketWatch
B. Riley’s stock soars 30% after bank agrees to sell Great American to Oaktree for almost $400 million
Investment bank’s stock is down 73% in the year to date amid regulatory fallout over a loanOctober 14 -
Business - MarketWatch
Amgen’s stock falls as analyst warns that hype around obesity drug is baked in
Truist analyst Srikripa Devarakonda backs away from bullish call as competition mutes potential for biotech’s drug pipeline.October 14